Daratumumab and hyaluronidase-fihj (Darzalex Faspro) Drug Info
Pharmaceuticals | Free Full-Text | Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
Impressive Results With Daratumumab Plus Lenalidomide/Dexamethasone in Multiple Myeloma - The ASCO Post
Subcutaneous daratumumab plus pomalidomide-dexamethasone: an effective treatment option for MM - BJH
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma | Advances in Therapy
Daratumumab Alone or in Combination with Lenalidomide/Dexamethasone or Pomalidomide/Dexamethasone for Relapsed/Refractory MM | Research To Practice
Relapsed: D + PD Treatment | DARZALEX® IV (daratumumab)
Subcutaneous daratumumab plus pomalidomide and dexamethasone in R/R MM - Medical Conferences
Multiple Myeloma Support + Trials
Phase Ib MMY1001: Daratumumab Plus Pom/Dex for Patients With R/R MM - ppt download
Suggested options for the treatment of relapsed multiple myeloma in... | Download Scientific Diagram
FDA
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment | Leukemia
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma - Zhou - 2020 - Cancer Medicine - Wiley Online Library
APOLLO trial results: Addition of daratumumab to pomalidomide + dexamethasone in relapsed/refractory multiple myeloma
Daratumumab Alone or in Combination with Lenalidomide/Dexamethasone or Pomalidomide/Dexamethasone for Relapsed/Refractory MM | Research To Practice
Omnihealth Practice | APOLLO: Phase 3 randomized study of subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
Relapsed: D + PD Treatment | DARZALEX® IV (daratumumab)
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial - The Lancet Oncology
When and How to Treat Relapsed Multiple Myeloma | American Society of Clinical Oncology Educational Book
APOLLO Study | Int'l Myeloma Foundation
